Home/ Supplements/ Phosphorus/ AminoLean x Chase Byrd Cherry On Top

AminoLean x Chase Byrd Cherry On Top

product on market Powder RSP Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The product contains an amino acid blend and energy components designed to support muscle recovery and cognitive focus. Research on these types of blends generally shows moderate evidence for performance support, though specific efficacy for this formulation is limited. The ingredient profile is associated with a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for AminoLean x Chase Byrd Cherry On Top
Open Full PDF View on NIH DSLD →
Details

Label Data

9.6 Gram(s)
Serving Size
30
Servings
Other Combinations
Product Type
40%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

80 mg (6% DV)
Within RDA (0.1× RDA) 13 studies (A:0, B:3)
Sodium
120 mg (5% DV)
5 Gram(s)
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)
Weight Management Blend
1.5 Gram(s)
Energy and Focus Blend
130 mg

Other Ingredients

Natural & Artificial Flavors Citric Acid Maltodextrin Sucralose Silicon Dioxide Cellulose Gum Xanthan Gum Carrageenan
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Mix 2 scoops (1 serving) of AminoLean in 8-10oz of cold water anytime throughout the day. Recommended use: For anytime energy: Take 1 or more servings first thing in the morning and/or between meals. For pre-workout energy: Take 1-3 servings 20-30 minutes before training. For recovery: Take 1-2 servings after training and/or between meals. Do not consume more than 6 scoops (3 servings) in a 24 hour period.

Before exercise

Warnings & Precautions

Contains milk

Warning: Keep out of reach of children. Not for use for those under the age of 18, women that are pregnant, or nursing, or those that are sensitive to caffeine and beta-alanine.

Consult your physician before using this product if you are taking any medication or under a physician's care for a medical condition. Not for use for those under the age of 18, women that are pregnant, or nursing, or those that are sensitive to caffeine and beta-alanine.

Do not consume caffeine from other sources while taking this product as too much caffeine may cause nervousness, irritability, sleeplessness, and occasionally rapid heartbeat. Discontinue use two weeks prior to surgery.

Formulation Notes

AminoLean is a pre-workout supplement designed to boost your performance and make the most of every workout. AminoLean is simple to take before a workout or as a daily supplement for anybody looking to improve their overall fitness performance. Our mission is to help you become the best version of yourself. So set up a goal, fuel up, achieve a personal best, recover and repeat! Anytime energy & performance Weight management support

130mg Energy & Focus Blend made from fermented tea leaves to support energy levels, focus and alertness. Amino Acids for muscle recovery Comprehensive blend of amino acids to boost performance and support muscle development & repair. CLA, carnitine, green tea extract and green coffee extract promote weight management.

Zero sugar Gluten free

Third party tested Limited Edition

Cherry On Top Natural & Artificial Flavors

CarnoSyn Carnosine Synthesizer InnovaTea

Additional Information

RSP Clean Active Nutrition

For this Limited Edition flavor, we have partnered with fitness influencer Chayse Byrd. With her passion for fitness and drive to help people reach their goals, she has built a dedicated following and is an inspiration to many.

Made in the USA This product contains ingredients of international and domestic origin.

Keep tightly closed in a cool, dry place. Avoid exposure to excessive heat.

Metadata

Product Details

UPC / SKU8 50019 46945 5
DSLD Entry Date2024-06-20
Product TypeOther Combinations
FormPowder
BrandRSP
DSLD ID310391
Data Updated2026-04-11
Research

Research Evidence

46
Research Sources
55
Avg Quality
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020 PubMed DOI
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018 PubMed DOI
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022 PubMed DOI
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022 PubMed DOI
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024 PubMed DOI
View all evidence for Phosphorus →
Compare

Similar Products

View all Phosphorus products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.